News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Medgenics, Inc. Half-Yearly Report The Six-Month Period Ended 30 June 2008
September 24, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MISGAV, Israel & LONDON--(BUSINESS WIRE)--Medgenics (AIM:MEDG) announces its half-yearly report for the six-month period ended 30 June 2008.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Asia
Europe
MORE ON THIS TOPIC
Layoffs
AC Immune Downsizes by 30%, Narrows Pipeline Focus
September 4, 2025
·
2 min read
·
Tristan Manalac
Cardiovascular disease
Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment
September 3, 2025
·
2 min read
·
Tristan Manalac
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
·
2 min read
·
Heather McKenzie
Cancer
Servier Commits up to $530M Into Eye Cancer Deal With IDEAYA
September 2, 2025
·
2 min read
·
Dan Samorodnitsky
